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Introduction
Serum paraoxonase 1 (PON1) is associated with plasma 
high-density lipoprotein, and prevents the oxidative modi-
fication of low-density lipoprotein1).  PON1 knockout 
mice are highly susceptible to developing atherosclerosis 
compared to wild-type control mice2).  Transgenic mice 
overexpressing PON1 display decreased atherosclerotic 
lesions3).  The serum PON1 concentration in relation to 
PON1-192 genetic polymorphism is signiﬁcantly lower in 
the RR (Arg/Arg) than in the QQ (Gln/Gln) genotype4). 
In Caucasian and Japanese diabetic patients, the R allele 
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increases the ischemic heart disease risk5-8).  However, 
Bhattacharyya T. et al. reported that the Q allele increases 
major adverse cardiac events in patients undergoing diag-
nostic coronary angiography9).  Thus, the relation between 
PON1-192 genetic polymorphism and atherosclerosis is 
controversial.  Here, we investigated the relation of the 
carotid artery IMT with genotypes of PON1 in Japanese 
diabetic patients, and examined their clinical data, because 
IMT values of the carotid arteries correlate with the pro-
gression of systemic atherosclerosis.
Subjects and Methods
1. Study subjects
The study subjects were 155 consecutive Japanese 
patients with type 2 diabetes aged from 40 to 79 years 
who were treated at our hospital.  These subjects had no 
history of major cardiovascular events and did not suffer 
from severe nephropathy.  Written, informed consent was 
obtained from the subjects who agreed to participate in 
the study, and the study was approved by the institutional 
review committee.  Since the QQ group was very small, the 
subjects were divided into two groups based on the geno-
type of PON1.  One group consisted of patients carrying 
two R alleles (RR group) and the other group consisted of 
patients carrying one or two Q alleles (Q group).  The char-
acteristics of the subjects are presented in Table 1.
2. Genotyping of PON1-192
Genomic DNA was extracted and puriﬁed from peripher-
al blood with the QIAamp Blood Kit (QIAGEN, Germany). 
For the genotyping of PON1, we used the polymerase 
chain reaction-restriction fragment length polymorphism 
(PCR-RFLP) method.  We used the primers described by 
Kujiraoka et al.: 5’-TAT TGT TGC TGT GGG ACC TGA 
G-3’(sense primer) and 5’-CTT GCC ATC GGG TGA AAT 
GTT G-3’ (antisense primer)4).  PCR was performed with 
30 cycles of amplification with annealing at 60°C.  The 
PCR products (193 bp) were digested with the AlwI restric-
tion enzyme, separated by 3.0% agarose gel electrophore-
sis, and visualized using ethidium bromide.  Genotype Q 
(Gln192) corresponded to 193-bp fragments and genotype 
R (Arg192) corresponded to 63- and 130-bp fragments.
3. Laboratory measurements
Fasting blood samples were drawn from the subjects, and 
Table 1  Clinical characteristics of the PON1-192 genotype groups
Characteristics Genotype   and   P-value
RR group Q group (QR and QQ genotypes) P-value
N 67 88(QR:70, QQ:18)
Sex (M/F) 44/23 53/35 0.488a
Age (years)  60.7±8.7  60.8±8.9 0.971b
Diabetes duration (years)   9.9±8.8  11.7±8.7 0.128c
Body mass index (kg/m2)  23.6±3.2  23.6±3.1 0.968b
HbA1c (JDS) (%)   8.4±2.7   7.8±1.9 0.160c
Fasting glucose (mg/dl) 201.7±102.6 174.1±68.6 0.301c
Total cholesterol (mg/dl) 202.7±37.1 202.2±36.1 0.930b
HDL cholesterol (mg/dl)  52.5±14.1  54.6±14.7 0.934c
LDL cholesterol (mg/dl) 120.7±32.6 119.3±33.5 0.799b
Triglycerides (mg/dl) 144.8±85.6 153.2±113.4 0.475c
Creatine (mg/dl) 0.849±0.314 0.885±0.537 0.506c
Systolic blood pressure (mmHg) 139.4±18.6 143.9±23.0 0.200b
Diastolic blood pressure (mmHg)  80.5±10.7  80.8±12.7 0.893b
Data are the mean±S.D.  P<0.05 was regarded as signiﬁcant.
a χ 2-test
b Student’s t-test
c Mann-Whitney’s U test
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serum total and HDL cholesterol, triglyceride, creatinine, 
plasma glucose, and HbA1c (JDS) levels were determined 
by the clinical research center of our hospital, following 
standard laboratory protocols.  LDL cholesterol values 
were calculated using the Friedewald equation.
4. B-mode ultrasonography
We used B-mode ultrasound imaging with 7.5-MHz 
transducers giving an axial resolution of 0.1 mm (appara-
tus, Toshiba SSA-370A; probe, PLM-703AT).  All exami-
nations were performed by a single trained sonographer. 
The IMT measurements were conducted as described in a 
previous report10).  The IMT of the far wall was measured 
on a longitudinal scan of the common carotid arteries at a 
point about 10 mm proximal to the beginning of the dila-
tion of the bulb.  We chose an area that was smooth, and 
avoided areas of focal thickening.  We measured the IMT 
value of the left and right carotid arteries in each patient, 
and the average IMT value was used as a representative 
value for each individual in the statistical analysis.
5. Statistical analysis
Data are expressed as the mean ± S.D.  The normality of 
continuous variables was checked.  When the data showed a 
normal distribution with equal variance, we used Student’s 
t-test.  When the data showed a normal distribution with 
an unequal variance, we used Welch’s t-test.  When the 
data did not show a normal distribution, we used Mann-
Whitney’s U test.  Values of P<0.05 were regarded signiﬁ-
cant.  We performed the analyses using Statcel 2 (OMS 
Publishing Inc., Japan).
Results
1. Characteristics of the study subjects
There were no signiﬁcant differences in the clinical char-
acteristics of the RR and Q groups.
2. Genotyping of PON1-192
The genotypes were determined using the PCR-RFLP 
method.  The sequenced PCR products were consistent 
with the reported data (data not shown).  The results of the 
genotypes are listed in Table 2.  The PON1 genotypes fre-
quencies were as follows: 18QQ (0.116), 70QR (0.452) and 
67RR (0.432).  The prevalence of the Q allele was 0.342 
and that of the R allele was 0.658, comparable to those of 
healthy Japanese volunteers studied previously4).  The dis-
tribution of PON1-192 genotypes showed Hardy-Weinberg 
equilibrium.
3. IMT measurements
The IMT values are shown in Table 3.  IMT of the RR 
group was significantly greater (1.08±0.41 mm, n=67) 
than that of the Q group (0.95±0.27 mm, n=88, P=0.023), 
although there was no significant difference between the 
two groups in clinical characteristics (Table 1).
Discussion
This study investigated the association between the 
PON1-192 genotypes and IMT values of carotid arteries, 
a measure that indicates the progression of systemic ath-
erosclerosis.  Our results indicate that the PON1-192 RR 
Table 2  Genotype and allele distribution of the study subjects
Genotype Frequency (n=155) Allele Frequency (n=310)
QQ 0.116 (18) Q 0.342 (106)
QR 0.452 (70) R 0.658 (204)
RR 0.432 (67)
Table 3   PON1-192 genotypes and IMT values of both 
genotypes in type 2 diabetic patients
Genotype   and   P-value
RR Q group (QR+QQ) P-value
N 67 88 (70+18)
IMT (mm) 1.08±0.41 0.95±0.27 0.023
Data are the mean±S.D.  P<0.05 was regarded as signiﬁcant. 
The P-value was calculated by Welch’s t-test.
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genotype may be associated with intima-media thickening 
of carotid arteries.  Kujiraoka et al. reported that the RR 
group had a higher paraoxonase activity4).  Also Aviram 
reported that PON1 has phospholipase A2-like activity, 
and it could form lysophosphatidylcholine (LPC) from 
phosphatidylcholine11).  LPC exhibits marked atherogenic 
activity12-13). PON1-192 RR may have a larger amount of 
phospholipase A2-like activity, by which LPC might be 
formed.  Thus, a larger atherogenic LPC might advance 
intima-media thickening of carotid arteries in PON1-192 
RR patients.  However, appropriate experiments are needed 
to test this hypothesis.  Hu et al. reported that, in Chinese 
diabetic patients, IMT values of carotid arteries were signif-
icantly greater in the RR group than in both the QR and QQ 
groups14).  Their findings correspond with ours, but total 
cholesterol and LDL cholesterol values in the RR group 
were significantly higher than those in the QR and QQ 
groups in their study.  High LDL cholesterol values usually 
cause systemic atherosclerosis.  High total cholesterol and 
LDL cholesterol values would explain intia-media thicken-
ing of the carotid arteries.  In our results, the clinical char-
acteristics of the subjects did not show any signiﬁcant dif-
ferences.  Thus, we conjecture that genetic polymorphism 
of PON1-192 may be a major cause of increased IMT val-
ues in the carotid arteries.  The RR group of our study had 
longer diabetic duration (9.9±8.8 years) and higher HbA1c 
values (8.4±2.7 %) than those of the Chinese RR group 
(7.9±4.0 year, 7.56±1.5 % ).  Namely, our study subjects 
had been more strongly affected by the diabetic condition. 
Diabetes is major cause of atherosclerosis.  Luersen report-
ed that a group of healthy males with the PON1-192QR 
polymorphism had a higher pro-inflammatory cytokine 
TNF-alpha level than a QQ group15).  TNF-alpha has ath-
erogenic effects16).  Thus, the PON1-192 RR genotype may 
be associated with intia-media thickening of the carotid 
arteries.  However, our ﬁndings need to be conﬁrmed in fur-
ther studies, especially in a larger study population.
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